scholarly journals Group Cognitive-Behavioral Therapy and Health-Related Quality of Life in Females With Premenstrual Syndrome

2016 ◽  
Vol In Press (InPress) ◽  
Author(s):  
Maryam Izadi-Mazidi ◽  
Iran Davoudi ◽  
Mahnaz Mehrabizadeh
SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A286-A287
Author(s):  
J C Ong ◽  
S C Dawson ◽  
J M Mundt ◽  
E Adkins ◽  
C Moore

Abstract Introduction The purpose of this study was to conduct a feasibility trial for a novel cognitive behavioral therapy (CBT-H) aimed at improving health-related quality of life (HRQoL) in people with hypersomnia. Methods Participants were 35 adults (32 female, mean age=32.0 years, SD=12.9) with an established diagnosis of Narcolepsy Type 1 (n=12), Type 2 (n=11), or Idiopathic Hypersomnia (n=12). Participants were assigned to individual (n=19) or group (n=16, 3-5 per group) format of a 6-session, manualized CBT-H, delivered using live videoconferencing. Key components of CBT-H included structuring daytime behaviors (e.g., planned naps), emotion regulation techniques, and energy management strategies. Outcome measures for HRQoL included PROMIS measures for depression, anxiety, self-efficacy, and social isolation. Other clinical outcome measures included the Patient Health Questionnaire (PHQ) and Epworth Sleepiness Scale (ESS). Exit interviews were used to collect qualitative data to inform acceptability of the intervention. Results Intent-to-treat analyses were conducted on the entire sample with the last observation carried forward for 3 participants who did not provide post-treatment data. Paired-samples t-test revealed a significant reduction on PROMIS depression (t[34]=2.05, p=0.0486, d=-0.35), and significant increases on PROMIS general self-efficacy (t[34]=3.64, p=0.0009, d=0.62) and self-efficacy managing social interactions (t[34]=2.14, p=0.0396, d=0.36). Significant reductions were also observed on the ESS (t[34]=2.07, p=0.0458, d=-0.35) and PHQ (t[34]=4.42, p<.0001, d=-0.75). Mixed-design ANOVAs revealed no significant differences on hypersomnia diagnosis or treatment format. Qualitative data supported the acceptability of telehealth delivery with mixed opinions regarding the format and number of sessions. Conclusion These findings support the acceptability of a novel CBT-H delivered using a telehealth model and the feasibility of reducing excessive sleepiness and improving HRQoL, particularly in the domains of self-efficacy and depression, in people with narcolepsy and idiopathic hypersomnia. Support This study was supported by grant 185-SR-17 from the American Sleep Medicine Foundation.


2017 ◽  
Vol 45 (4) ◽  
pp. 452-458
Author(s):  
Birgitta Ojala ◽  
Clas-Håkan Nygård ◽  
Heini Huhtala ◽  
Seppo T. Nikkari

The aim of this study was to evaluate the effectiveness of vocationally outpatient oriented rehabilitation on an intervention group, compared with a control group that did not take part in the intervention. The groups were compared for health-related quality of life (HRQoL) by the quantitative indicator RAND 36. Data were obtained by a self-report at baseline and at nine months follow-up. Differences between base-line and follow-up were analyzed within group and between the groups. The study population consisted of 751 municipal employees aged between 26 and 64 years; an intervention with 463 women and 115 men ( n = 578), and a control group with 138 women and 35 men ( n = 173). In this study we focused on those who had answered to all questions in RAND 36, thus 581 remained. Of these, 388 were in the intervention group (mean age 49.0 years) and 110 in the control group (mean age 48.4 years). Intervention was based on cognitive behavioral therapy. Participants in the 9-month outpatient intervention group showed statistically significant increase in all eight RAND 36 areas. Most improvement was seen in the psychosocial functioning index ( p = 0.002). Although there were no statistically significant changes in RAND 36 components in the control group, difference in changes between groups were seen in energy and fatigue ( p < 0.001), social functioning ( p = 0.032) and general health perceptions 0.027 in favor of the intervention group. The results suggest that a cognitive behavioral intervention as an early rehabilitation program is effective in increasing employees’ quality of life, as measured by RAND 36.


2021 ◽  
Author(s):  
Sanam Borji-Navan ◽  
Sakineh Mohammad-Alizadeh-Charandabi ◽  
Khalil Esmaeilpour ◽  
Mojgan Mirghafourvand ◽  
Ali Ahmadian-Khooinarood

Abstract Background: Premenstrual Syndrome (PMS) is a common problem among women of reproductive age, affecting various aspects of their lives. There are very limited studies investigating the effect of Internet-Based Cognitive-Behavioral Therapy (ICBT) on PMS. We aimed to investigate the effect of ICBT on symptom severity of women suffering from PMS and their quality of life in the perimenstrual and late follicular periods. Methods: Ninety-two university students aged 18-35 years with moderate to severe PMS were allocated into two groups of 46 using block randomization. The intervention group underwent ICBT for two menstrual cycles, while the control group received no intervention. All participants filled the Daily Record of Severity of Problems (DRSP) for two menstrual cycles and the Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF) on days 1-2 and 11-13 of the menstrual cycle pre- and post-intervention. Data were analyzed using univariate general linear models. Results: Four students in the intervention group were lost to follow-up. Post-interventionally, the mean score of total PMS symptoms was significantly lower in the intervention group than the control group (10.4 vs. 20.2, adjusted difference: -9.9 [95% CI: -13.3 to -6.6]) and perimenstrual quality of life was significantly higher (64.2 vs. 50.3, 14.1 [8.5 to 19.8]). However, there was no significant intergroup difference in the late follicular quality of life (68.3 vs. 67.3, 1.9 [-4.4 to 8.1]). Conclusions: Internet-Based Cognitive-Behavioral Therapy could effectively reduce PMS symptom severity and improve perimenstrual quality of life, with no significant effect on the late follicular quality of life. Trial registration: The Iranian Registry of Clinical Trials, Identifier: IRCT20100414003706N34, Registered 19 June 2019, https://www.irct.ir/trial/38394


Sign in / Sign up

Export Citation Format

Share Document